Pharmacorp enters definitive deals for two pharmacies

Mr. Alan Simpson reports PHARMACORP TO ACQUIRE TWO PHARMACIES IN WESTERN CANADA Pharmacorp Rx Inc. has entered into definitive share purchase agreements, each dated Aug. 29, 2025, to acquire from the same arm's-length vendors a 100-per-cent interest in two Pharmachoice Canada bannered pharmacies located in Western Canada, one of which includes the associated lands and building. The aggregate purchase price for the acquisitions is $3.4-million, subject to customary adjustments. In accordance with the agreements, 75 per cent of the purchase price will be satisfied with cash on hand, and 25 per cent will be satisfied by the issuance of common shares of Pharmacorp. The deemed price for the common shares will be equal to the volume-weighted average trading price of the common shares on the TSX Venture Exchange during the 10-day period ending at the close of business on the third business day prior to the closing date of the acquisitions. The acquisitions are expected to close on or about Oct. 1, 2025, subject to satisfaction of customary closing conditions. No finders' fees are payable in respect of the acquisitions. "These transactions reflect our ability to originate, negotiate and close accretive acquisitions as initially signalled in our previously announced letters of intent," said Alan Simpson, executive chair of Pharmacorp. "They underscore our internal capacity to convert opportunities from the strategic alliance with Pharmachoice Canada into tangible growth." About Pharmacorp Rx Inc. Pharmacorp currently operates four Pharmachoice Canada bannered pharmacies in Canada and will continue to acquire Pharmachoice Canada branded pharmacies as they come to market in conjunction with its strategic alliance agreement with Pharmachoice Canada. The corporation will also acquire independently owned non-Pharmachoice Canada bannered pharmacies in Canada and, thereafter, continue to operate such acquired pharmacies under a Pharmachoice Canada banner. Pharmacorp shares trade on the TSX Venture Exchange under the symbol PCRX. We seek Safe Harbor.